|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 8 December 2022, 11:59. The announcement is marked as price sensitive, and is 1 page(s) in length and 151.76kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| NASDAQ Progression - Medlab Clears SEC Comments | 8 December 2022, 11:59 |
| First Tranche IP Royalty Payment from Pharmacare | 1 December 2022, 8:17 |
| Medlab receives UK Import Permission from MHRA for NanaBis | 25 November 2022, 9:04 |
| Jefferies HealthCare Conference NanoCelle Presentation | 16 November 2022, 17:06 |
You must be logged in to post a reply.
Medlab Clinical 